AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 162 min read$VRSK

Mann Elizabeth sold $72K of VRSK

Mann Elizabeth (Chief Financial Officer) sold 400 shares of Verisk Analytics, Inc. (VRSK) at $179.54 on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mann Elizabeth
Published Jun 16, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$VRSK
Neutral
high confidence
Mentioned
$VRSK
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

This provides incremental transparency on insider activity but does not include new operational, financial, or regulatory information that would typically drive repricing.

02

Market read

A routine CFO 10b5-1 sale is unlikely to materially change valuation expectations, but it can be used as a minor sentiment datapoint.

03

What to watch

Traders may over-weight small insider sales; the key differentiator is the pre-arranged 10b5-1 designation, which reduces interpretive value.

Relevance 2/10Novelty 5/10Timing: Filed 2026-06-16; sale executed 2026-06-15.

Background

The article is an SEC Form 4 insider transaction disclosure for Verisk Analytics, reporting a CFO sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VRSKNeutralHigh confidence
Context

Verisk CFO Elizabeth Mann sold 400 shares on 2026-06-15 under a pre-arranged 10b5-1 plan, worth about $71.8K.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan and small dollar value relative to company size.

Market effects

Sector

No sector read-across; this is company-specific ownership-change disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because it’s a 10b5-1 plan, the sale may reflect scheduled liquidity needs rather than bearish fundamentals.

Key entities

  • issuer
    Verisk Analytics, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Mann Elizabeth

    CFO who sold shares; transaction details are reported on SEC Form 4.

  • trading mechanism
    Rule 10b5-1 plan

    Indicates the sale was pre-arranged, generally lowering interpretive signal.

Read at source← All news

Related articles

AUG 8
$VRSKMedAI 8/10

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) reported Q2 2026 revenue of $806 million, up 4.3% reported and 5.8% organic constant currency. Adjusted EBITDA was $464 million, up 7.4% on the same basis. Subscription revenue was 83% of total, and diluted adjusted EPS was $1.98. Full-year guidance was reaffirmed: revenue $3.19B to $3.24B and EPS $7.45 to $7.75.

aol.com6 min
AUG 7
$VRSKMedAI 8/10

Verisk Ordered to Move Ahead With $2.35 Billion AccuLynx Merger

A Delaware Chancery Court judge ordered Verisk Analytics to proceed with its $2.35 billion merger with AccuLynx, rejecting AccuLynx’s bid to raise the deal price over antitrust clearance concerns. The judge cited willful conduct by AccuLynx for a failed closing condition and awarded AccuLynx damages for direct costs plus interest. The deal still requires HSR Act clearance and FTC approval.

news.bloomberglaw.com4 min
JUL 29
$VRSKMedAI 8/10

[VRSK Q2 2026 Earnings Call] Verisk Q2 Organic Revenue Hits 5.8% as XactAI Users Jump 10x to 7,000, but Transactional Drag Persists — BigGo Finance

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806 million, up 5.8% organic constant currency, driven by 8% subscription growth (83% of revenue). Transactional revenue fell 4.2% due to softer commercial property quotes and weaker weather demand. XactAI users rose 10x to 7,000. Full-year guidance of $3.19–$3.24B revenue and $1.79–$1.83B adj. EBITDA was reaffirmed.

finance.biggo.com7 min
JUL 29
$VRSKMed

Verisk Vaults on Releasing Q2 Results

Verisk (NASDAQ: VRSK) reported Q2 results for the quarter ended June 30, 2026. Net income fell 9.8% to $229 million, citing higher tax rate, net interest expense, and legal fees tied to litigation. The company paid a $0.50 dividend per share and launched a $200 million accelerated share repurchase, with an initial delivery of 949,190 shares at $179.10. Shares rose 9.6% to $221.87.

baystreet.ca3 min